Maybe it's worth mentioning that if you have any kind of insurance, you actually pay far, far less than that. US pricing is weird for most medical things.
As a person with diabetes (though I do not need insulin at the moment) I may notice this stuff more than most people.
While that's true, I'm thinking in terms of WAC price here, which isn't always cost per dose. IFN-alpha WAC price is about $770, whereas insulin from Eli Lilly has a WAC price of $275.
Of course the point about insurance will also apply to peg-IFN-lambda if it makes it to market as well, but I expect the WAC price for *one course* of this therapy to be similar to the WAC price of *one course* of similarly-manufactured therapies.
It usually isn't useful to think about what "one dose" costs for any therapy because dosing can be so wildly different across therapies. Generally you get better comparability if you think about price per course.
You're right of course--as is Vox--that insulin really ought to be cheaper in the US. But since it isn't, it isn't.
Man, am I prolix.
Insulin costs up to hundreds of dollars *per month*, not per dose, in the USA, and that's artificial. It's much cheaper overseas. See https://www.vox.com/2019/4/3/18293950/why-is-insulin-so-expensive
Maybe it's worth mentioning that if you have any kind of insurance, you actually pay far, far less than that. US pricing is weird for most medical things.
As a person with diabetes (though I do not need insulin at the moment) I may notice this stuff more than most people.
While that's true, I'm thinking in terms of WAC price here, which isn't always cost per dose. IFN-alpha WAC price is about $770, whereas insulin from Eli Lilly has a WAC price of $275.
Of course the point about insurance will also apply to peg-IFN-lambda if it makes it to market as well, but I expect the WAC price for *one course* of this therapy to be similar to the WAC price of *one course* of similarly-manufactured therapies.
It usually isn't useful to think about what "one dose" costs for any therapy because dosing can be so wildly different across therapies. Generally you get better comparability if you think about price per course.
You're right of course--as is Vox--that insulin really ought to be cheaper in the US. But since it isn't, it isn't.
I hate to say this, but since we're in an internet comment thread, I'm compelled to make the point that you *wrote* "per dose."
Yeah, I did. My bad. I was thinking about how the IFN lambda thing is a one-dose treatment. Oops; I was definitely looking at WAC prices though.